NCT06726070View on ClinicalTrials.gov

Investigation of the Diagnostic Role of miRNAs in PCa and BPH

CompletedOBSERVATIONAL
Enrollment

57

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

December 5, 2022

Study Completion Date

March 2, 2023

Conditions
Benign Prostate Hypertrophy(BPH)Prostate Cancer (Adenocarcinoma)
Trial Locations (1)

07400

Alanya Alaaddin Keykubat University Training and Research Hospital, Antalya

All Listed Sponsors
lead

Alanya Alaaddin Keykubat University

OTHER

NCT06726070 - Investigation of the Diagnostic Role of miRNAs in PCa and BPH | Biotech Hunter | Biotech Hunter